25,148.11
+467.01
(+1.89%)
8,371.11
+186.73
(+2.28%)
4,903.74
+163.25
(+3.44%)
3,939.57
-16.01
(-0.405%)
4,769.77
-17.01
(-0.355%)
14,739.42
-39.98
(-0.271%)
64,591.9900
-164.2900
(-0.254%)
22/01/2025 11:26
大行報告 | 蔚小理、藥明系、電訊股、比亞迪及領展最新評級/目標價,一表盡掌握
.高盛點評蔚小理,降理想(02015)、蔚來(09866)目標卻升小鵬(09868)目標
.高盛調升藥明系目標價,其中藥明康德(02359)目標由58元升至62.4元
.大摩看好中資電訊股,皆維持超配評級



1069,,新聞,專題透視,reports